Novavax Inc vs Super Micro Computer Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Super Micro Computer Inc trades at $30.23 (market cap $15.41B). The key difference: Super Micro Computer Inc is far larger — about 11.9× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SMCI | |
|---|---|---|
Market Cap | $1.30B | $15.41B |
Sector | Health | Technology |
52-Week High | $11.19 | $60.71 |
52-Week Low | $6.22 | $20.53 |
Enterprise Value | $800.50M | $22.93B |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →